Sandra Le Quellec, Global Clinical Development Director of Hamatology/Gene Therapy at the CSL, shared a post on LinkedIn:
“It’s been a year already since I started my new role as a Global Clinical Development Director, Hematology/Gene Therapy.
Soaring into new horizons means accepting and managing some turbulences, but always with a focus that remains unwavering: to bring safe and effective innovative treatments to patients with hemophilia.
I am excited I have embarked on this adventure: this past year has been incredibly rewarding, filled with continuous learning, strategic thinking, and enriching multidisciplinary collaboration. Let’s continue the mission with a patient-focused mindset.”
Source: Sandra Le Quellec/LinkedIn